|
The patient ultimately required a hysterectomy due to excessive vaginal bleeding, subsequently developed dic, and, unfortunately, did not survive.[disseminated intravascular coagulation] , had worsening medical condition [condition aggravated] , the patient ultimately required a hysterectomy due to excessive vaginal bleeding, subsequently developed dic, and, unfortunately, did not survive.[device ineffective] , md placed jada on a patient 7 weeks postpartum.[device use issue].Case narrative: this spontaneous report originating from united states was received from a consumer referring to a female patient of unknown age.The patient concurrent condition, concomitant medication, past drug/allergy was not reported.This report concerns 1 patient(s) and 1 device(s).On an unknown date in 2026, the patient's menses had returned, and the bleeding became extremely heavy and patient needed a dilation and curettage (d&c) (historical condition).Two hours post d&c, the patient experienced heavy vaginal bleeding and the doctor had placed the vacuum-induced hemorrhage control system (jada system) on a 7 week postpartum haemorrhage patient (device use issue) via vaginal route (strength, dose, frequency, lot number and expiration date were not reported).Patient did well and had no complaints.Later on, hospital had informed that the patient ultimately required a hysterectomy due to excessive vaginal bleeding (device ineffective), subsequently developed disseminated intravascular coagulation (dic), had worsening medical condition (condition aggravated), and ended up passing away due to unknown cause of death.It was unknown if autopsy was performed or not.The reporter causality assessment was not reported.Upon internal review, the events disseminated intravascular coagulation, condition aggravated were determined to be medically significant.Upon internal review, the event device ineffective was determined to be serious due to required intervention (devices).Case comments: based on the clinically relevant information currently available for this individual case and the fda decision tree, the case was considered reportable, since the causal role of the device in the patient¿s deterioration and death could not be ruled out.
|
|
Follow up information received on 21-apr-2026.This is final report.Component code included from international medical device regulators forum website "annexes a-g: imdrf terminologies for categorized adverse event reporting (aer) - medical device problem device code value.Insufficient component information [g07003]: there is not yet enough information available to classify the medical device component.A complaint sample was not available for evaluation, therefore the complaint could not be substantiated.The device is assembled per specifications where in-process and final inspections are conducted by trained personnel.No outcome from the investigation could be determined since a complaint sample has not been provided.If the complaint sample becomes available, this complaint will be re-opened and additional investigation may be performed.
|